当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析 - 现金流量表

健帆生物

(300529)

  

流通市值:109.10亿  总市值:170.02亿
流通股本:5.12亿   总股本:7.99亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金605,506,283.552,968,564,959.492,308,282,415.791,655,963,431.65
收到的税费返还427,508.821,412,149.211,426,857.541,188,340.94
收到其他与经营活动有关的现金52,637,880.561,223,715.0756,838,321.845,571,886.6
经营活动现金流入的平衡项目0000
经营活动现金流入小计658,571,672.873,031,200,823.772,366,547,595.131,702,723,659.19
购买商品、接受劳务支付的现金108,555,827.23337,539,883.33281,607,229.43162,601,482.2
支付给职工以及为职工支付的现金133,698,395.11619,071,241.96451,803,005.36308,860,984.94
支付的各项税费69,901,768.04469,527,502.11357,955,996.27228,484,393.21
支付其他与经营活动有关的现金77,361,893.68554,073,774.97403,576,558.51253,508,818.6
经营活动现金流出的平衡项目0000
经营活动现金流出小计389,517,884.061,980,212,402.371,494,942,789.57953,455,678.95
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额269,053,788.811,050,988,421.4871,604,805.56749,267,980.24
二、投资活动产生的现金流量:
收回投资收到的现金649,212,907.893,732,950,0001,545,083,634.461,030,000,000
取得投资收益收到的现金619,349.8942,089,876.6324,463,713.38,179,293.09
处置固定资产、无形资产和其他长期资产收回的现金净额1,454,9505,340,781.354,889,381.3569,825.35
投资活动现金流入的平衡项目0000
投资活动现金流入小计651,287,207.783,780,380,657.981,574,436,729.111,038,249,118.44
购建固定资产、无形资产和其他长期资产支付的现金52,431,942.8235,140,028.4179,475,487.15128,103,543.22
投资支付的现金2,129,950,0004,672,712,907.893,572,712,907.892,025,500,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,182,381,942.84,907,852,936.293,752,188,395.042,153,603,543.22
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,531,094,735.02-1,127,472,278.31-2,177,751,665.93-1,115,354,424.78
三、筹资活动产生的现金流量:
吸收投资收到的现金--0-
取得借款收到的现金34,691,084.41325,075,677.25294,425,852.51262,155,920.39
收到其他与筹资活动有关的现金8,380,023.6694,342,749.3650,000,00050,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计43,071,108.07419,418,426.61344,425,852.51312,155,920.39
偿还债务支付的现金16,530,548.64651,161,297.67364,161,297.67254,756,297.67
分配股利、利润或偿付利息支付的现金1,373,115.22340,117,509.67334,666,001.54330,443,225.55
支付其他与筹资活动有关的现金9,224,864.26417,960,680.74373,288,104.48373,288,104.48
筹资活动现金流出平衡项目0000
筹资活动现金流出小计27,128,528.121,409,239,488.081,072,115,403.69958,487,627.7
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额15,942,579.95-989,821,061.47-727,689,551.18-646,331,707.31
四、汇率变动对现金及现金等价物的影响145,379.17427,871.75-787,737.5195,710.86
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,245,952,987.09-1,065,877,046.63-2,034,624,149.06-1,012,322,440.99
加:期初现金及现金等价物余额1,675,666,241.252,741,543,287.882,741,543,287.882,741,543,287.88
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额429,713,254.161,675,666,241.25706,919,138.821,729,220,846.89
补充资料:
净利润-814,186,376.79-550,755,750.67
资产减值准备-10,843,712.79-7,914,835.48
固定资产和投资性房地产折旧-119,604,861.51-55,528,555.62
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-119,604,861.51-55,528,555.62
无形资产摊销-4,311,430.23-2,127,318.41
长期待摊费用摊销-16,954,528.37-7,650,416.68
处置固定资产、无形资产和其他长期资产的损失--3,639,820.27--2,163,697.06
固定资产报废损失-1,041,823.84-253,599.81
公允价值变动损失--1,023,228.9--5,802,775.48
财务费用-63,713,298.39-32,560,826.4
投资损失--42,089,876.63--8,179,293.09
递延所得税--5,476,591.81--3,582,832.1
其中:递延所得税资产减少--4,233,114.23--893,879.2
递延所得税负债增加--1,243,477.58--2,688,952.9
存货的减少-41,562,239.31-64,913,204.11
经营性应收项目的减少--8,217,395.2--25,770,108.03
经营性应付项目的增加-451,180.84-52,033,519.42
其他-35,486,882.63-19,249,380.04
现金的期末余额-1,675,666,241.25-1,729,220,846.89
减:现金的期初余额-2,741,543,287.88-2,741,543,287.88
公告日期2025-04-162025-04-162024-10-192024-08-08
审计意见(境内)标准无保留意见
TOP↑